- Home
- PLX vs COE Comparison
PLX vs COE Comparison
Compare PLX & COE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLX | COE |
|---|---|---|
| Founded | 1993 | 2011 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 230.0M | 246.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PLX | COE |
|---|---|---|
| Price | $2.97 | $26.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 4.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.29 | N/A |
| Revenue Next Year | $16.65 | N/A |
| P/E Ratio | $43.14 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.32 | $13.60 |
| 52 Week High | $3.10 | $56.13 |
Technical Indicators
Market Signals| Indicator | PLX | COE |
|---|---|---|
| Relative Strength Index (RSI) | 72.63 | 37.13 |
| Support Level | $2.81 | $27.16 |
| Resistance Level | $3.03 | $28.00 |
| Average True Range (ATR) | 0.17 | 0.80 |
| MACD | 0.03 | 0.40 |
| Stochastic Oscillator | 93.00 | 34.12 |
Price Performance
Historical ComparisonAbout PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About COE 51Talk Online Education Group
51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Group operates in seven principal geographical area: China, Hong Kong, Philippines, Singapore, Malaysia, Thailand and Saudi Arabia.